SCHEMBL11913667

SCHEMBL11913667

Oc1ccc(/C=N/Nc2nc(Nc3ccccc3)nc(Nc3ccccc3)n2)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDX3X O00571 4/20 1.00
▸ MEN1 O00255 9/20 0.62
▸ KMT2A Q03164 9/20 0.62
▸ GAA P10253 7/20 0.62
▸ MAPT P10636 9/20 0.59
▸ HTT P42858 7/20 0.59
▸ KDM4E B2RXH2 5/20 0.59
▸ ALDH1A1 P00352 2/20 0.59
▸ TDP1 Q9NUW8 4/20 0.55
▸ NPC1 O15118 3/20 0.55
▸ RAB9A P51151 3/20 0.55
▸ L3MBTL1 Q9Y468 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ HPGD P15428 2/20 0.55
▸ HKDC1 Q2TB90 1/20 0.55
▸ KDM4C Q9H3R0 1/20 0.55
▸ NCOA1 Q15788 1/20 0.55
▸ NCOA3 Q9Y6Q9 1/20 0.55
▸ POLB P06746 4/20 0.55
▸ MAPK1 P28482 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1132125 0.83 MEN1 (0.71) DDX3XMEN1KMT2AGAAMAPT
SCHEMBL1132176 0.83 MEN1 (0.71) DDX3XMEN1KMT2AGAAMAPT
SCHEMBL30602635 0.83 MEN1 (0.71) DDX3XMEN1KMT2AGAAMAPT
SCHEMBL6414918 0.77 DDX3X (0.63) DDX3XMEN1KMT2AGAAMAPT
SCHEMBL11898668 0.76 KMT2A (0.83) DDX3XMEN1KMT2AGAAMAPT
SCHEMBL11898667 0.76 KMT2A (0.83) DDX3XMEN1KMT2AGAAMAPT
SCHEMBL8231988 0.76 DDX3X (0.61) DDX3XMEN1KMT2AGAAMAPT
SCHEMBL8238853 0.76 DDX3X (0.61) DDX3XMEN1KMT2AGAAMAPT
SCHEMBL14527789 0.76 DDX3X (0.61) DDX3XMEN1KMT2AGAAMAPT
SCHEMBL13380966 0.75 DDX3X (1.00) DDX3XMEN1KMT2AMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
WO-2011039735-A2 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2011-04-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF DDX3X, DDX21, DDX39B DDX3X 1/4885MEN1 1855/4885KMT2A 2610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback